CA Stock MarketDetailed Quotes

BriaCell Therapeutics Corp (BCT)

Watchlist
  • 6.010
  • -0.160-2.59%
15min DelayTrading Jan 23 11:42 ET
37.33MMarket Cap-0.13P/E (TTM)

BriaCell Therapeutics Corp (BCT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.78%-7.7M
-16.76%-28.17M
-101.51%-8.13M
-40.89%-7.16M
20.01%-5.92M
8.55%-6.96M
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
-87.29%-7.4M
Net income from continuing operations
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
Operating gains losses
-83.43%114.03K
98.10%-534.15K
92.39%-344.97K
98.96%-113.09K
-148.18%-764.26K
104.82%688.16K
-1,227.46%-28.14M
11.01%-4.53M
-1,922.27%-10.91M
-79.21%1.59M
Depreciation and amortization
0.00%26.66K
27.09%106.63K
-63.20%26.66K
598.53%26.66K
598.01%26.66K
598.19%26.66K
449.39%83.9K
1,797.43%72.44K
-0.05%3.82K
0.05%3.82K
Remuneration paid in stock
10.38%294.69K
-56.94%776.88K
--0
-42.68%224.82K
-43.00%285.09K
-49.99%266.97K
-17.76%1.8M
-29.21%377.89K
39.48%392.22K
87.43%500.16K
Other non cashItems
---89.49K
---56.47K
----
----
----
----
----
----
----
----
Change In working capital
110.80%227.65K
-127.04%-1.91M
-68.59%406.44K
-128.80%-1.08M
-52.78%870.11K
-1,268.76%-2.11M
299.70%7.05M
132.79%1.29M
2,154.47%3.74M
6,070.75%1.84M
-Change in receivables
143.29%887.86K
200.14%733.63K
100.07%514
-33.32%9.94K
4,201.17%358.24K
14,484.51%364.94K
-14,107.23%-732.58K
-18,411.89%-736.22K
349.87%14.91K
-142.06%-8.74K
-Change in prepaid assets
----
-76.85%492.28K
-42.83%758.57K
-120.94%-185.97K
128.40%291.53K
-139.65%-371.85K
148.35%2.13M
130.43%1.33M
199.96%888.22K
-428.26%-1.03M
-Change in payables and accrued expense
73.30%-660.22K
-155.36%-3.13M
-150.13%-352.65K
-131.77%-900.21K
-79.42%592.2K
-227.51%-2.47M
557.82%5.66M
68.13%703.4K
297.57%2.83M
1,047.78%2.88M
Cash from discontinued investing activities
Operating cash flow
-10.78%-7.7M
-16.76%-28.17M
-101.51%-8.13M
-40.89%-7.16M
20.01%-5.92M
8.55%-6.96M
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
-87.29%-7.4M
Investing cash flow
Cash flow from continuing investing activities
0.00%-75K
-1,021.44%-7.65M
-1,517.99%-7.39M
53.33%-105K
-75K
-75K
-681.8K
-456.8K
-225K
0
Net PPE purchase and sale
----
--0
----
----
----
----
---456.8K
----
----
----
Net business purchase and sale
0.00%-75K
-46.67%-330K
---75K
53.33%-105K
---75K
---75K
---225K
--0
---225K
--0
Net investment purchase and sale
----
---7.32M
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
0.00%-75K
-1,021.44%-7.65M
-1,517.99%-7.39M
53.33%-105K
---75K
---75K
---681.8K
---456.8K
---225K
--0
Financing cash flow
Cash flow from continuing financing activities
0
928.49%45.45M
206.79%13.56M
14.71M
5.22M
11.96M
11.75%4.42M
10.47%4.42M
0
0
Net common stock issuance
--0
909.91%44.63M
206.79%13.56M
--14.71M
--4.69M
--11.67M
11.79%4.42M
10.47%4.42M
--0
--0
Proceeds from stock option exercised by employees
--0
--821.02K
--0
--0
--527.76K
--293.25K
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
928.49%45.45M
206.79%13.56M
--14.71M
--5.22M
--11.96M
11.75%4.42M
10.47%4.42M
--0
--0
Net cash flow
Beginning cash position
1,117.25%10.49M
-95.94%862.09K
1,231.66%12.46M
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-48.22%21.25M
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
Current changes in cash
-257.80%-7.78M
147.24%9.63M
-2,571.62%-1.97M
240.27%7.45M
89.48%-778.61K
164.83%4.93M
-3.02%-20.39M
98.94%-73.61K
0.40%-5.31M
-87.29%-7.4M
End cash Position
-53.14%2.71M
1,117.25%10.49M
1,117.25%10.49M
1,231.66%12.46M
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
-81.36%6.24M
Free cash from
-10.78%-7.7M
-14.59%-28.17M
-81.02%-8.13M
-40.89%-7.16M
20.01%-5.92M
8.55%-6.96M
-3.53%-24.58M
58.86%-4.49M
4.65%-5.08M
-87.29%-7.4M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.78%-7.7M-16.76%-28.17M-101.51%-8.13M-40.89%-7.16M20.01%-5.92M8.55%-6.96M-1.61%-24.13M63.04%-4.04M4.65%-5.08M-87.29%-7.4M
Net income from continuing operations -42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M
Operating gains losses -83.43%114.03K98.10%-534.15K92.39%-344.97K98.96%-113.09K-148.18%-764.26K104.82%688.16K-1,227.46%-28.14M11.01%-4.53M-1,922.27%-10.91M-79.21%1.59M
Depreciation and amortization 0.00%26.66K27.09%106.63K-63.20%26.66K598.53%26.66K598.01%26.66K598.19%26.66K449.39%83.9K1,797.43%72.44K-0.05%3.82K0.05%3.82K
Remuneration paid in stock 10.38%294.69K-56.94%776.88K--0-42.68%224.82K-43.00%285.09K-49.99%266.97K-17.76%1.8M-29.21%377.89K39.48%392.22K87.43%500.16K
Other non cashItems ---89.49K---56.47K--------------------------------
Change In working capital 110.80%227.65K-127.04%-1.91M-68.59%406.44K-128.80%-1.08M-52.78%870.11K-1,268.76%-2.11M299.70%7.05M132.79%1.29M2,154.47%3.74M6,070.75%1.84M
-Change in receivables 143.29%887.86K200.14%733.63K100.07%514-33.32%9.94K4,201.17%358.24K14,484.51%364.94K-14,107.23%-732.58K-18,411.89%-736.22K349.87%14.91K-142.06%-8.74K
-Change in prepaid assets -----76.85%492.28K-42.83%758.57K-120.94%-185.97K128.40%291.53K-139.65%-371.85K148.35%2.13M130.43%1.33M199.96%888.22K-428.26%-1.03M
-Change in payables and accrued expense 73.30%-660.22K-155.36%-3.13M-150.13%-352.65K-131.77%-900.21K-79.42%592.2K-227.51%-2.47M557.82%5.66M68.13%703.4K297.57%2.83M1,047.78%2.88M
Cash from discontinued investing activities
Operating cash flow -10.78%-7.7M-16.76%-28.17M-101.51%-8.13M-40.89%-7.16M20.01%-5.92M8.55%-6.96M-1.61%-24.13M63.04%-4.04M4.65%-5.08M-87.29%-7.4M
Investing cash flow
Cash flow from continuing investing activities 0.00%-75K-1,021.44%-7.65M-1,517.99%-7.39M53.33%-105K-75K-75K-681.8K-456.8K-225K0
Net PPE purchase and sale ------0-------------------456.8K------------
Net business purchase and sale 0.00%-75K-46.67%-330K---75K53.33%-105K---75K---75K---225K--0---225K--0
Net investment purchase and sale -------7.32M------------------0------------
Cash from discontinued investing activities
Investing cash flow 0.00%-75K-1,021.44%-7.65M-1,517.99%-7.39M53.33%-105K---75K---75K---681.8K---456.8K---225K--0
Financing cash flow
Cash flow from continuing financing activities 0928.49%45.45M206.79%13.56M14.71M5.22M11.96M11.75%4.42M10.47%4.42M00
Net common stock issuance --0909.91%44.63M206.79%13.56M--14.71M--4.69M--11.67M11.79%4.42M10.47%4.42M--0--0
Proceeds from stock option exercised by employees --0--821.02K--0--0--527.76K--293.25K--0--0--0--0
Cash from discontinued financing activities
Financing cash flow --0928.49%45.45M206.79%13.56M--14.71M--5.22M--11.96M11.75%4.42M10.47%4.42M--0--0
Net cash flow
Beginning cash position 1,117.25%10.49M-95.94%862.09K1,231.66%12.46M-19.71%5.01M-57.55%5.79M-95.94%862.09K-48.22%21.25M-96.68%935.69K-81.36%6.24M-63.56%13.65M
Current changes in cash -257.80%-7.78M147.24%9.63M-2,571.62%-1.97M240.27%7.45M89.48%-778.61K164.83%4.93M-3.02%-20.39M98.94%-73.61K0.40%-5.31M-87.29%-7.4M
End cash Position -53.14%2.71M1,117.25%10.49M1,117.25%10.49M1,231.66%12.46M-19.71%5.01M-57.55%5.79M-95.94%862.09K-95.94%862.09K-96.68%935.69K-81.36%6.24M
Free cash from -10.78%-7.7M-14.59%-28.17M-81.02%-8.13M-40.89%-7.16M20.01%-5.92M8.55%-6.96M-3.53%-24.58M58.86%-4.49M4.65%-5.08M-87.29%-7.4M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More